-
Je něco špatně v tomto záznamu ?
Vaginal dryness: individualised patient profiles, risks and mitigating measures
V. Goncharenko, R. Bubnov, J. Polivka, P. Zubor, K. Biringer, T. Bielik, W. Kuhn, O. Golubnitschaja,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
BioMedCentral Open Access
od 2012
PubMed Central
od 2010 do Před 1 rokem
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
- Publikační typ
- časopisecké články MeSH
Vaginal dryness (VD) affects both pre- and postmenopausal women at any age. Since the hormonal regulation changes during the climacteric period are considered as being the main course of the VD, affected women prefer not to talk about the problem. However, the problem does exist, and unfortunately if any, relatively minor group in the population possesses the health literacy at sufficient level to understand that VD is a suboptimal health condition which carries a multi-factorial character. Thereby, some of the contributing factors are clearly preventable and, therefore, if treated properly, have a potential to milden the VD. Current chapter demonstrates specific signs and symptoms of Flammer syndrome in women suffering from vaginal dryness, although individualised patient profiles clearly discriminate between pre- and postmenopausal women regarding the subgroup-specific symptoms. Noteworthy, about 20% of the VD patients involved in the study notify a delayed or even impaired wound healing observed for themselves over a couple of years. Optimising modifiable risk factors accompanying FS phenotype at the level of primary prevention is strongly recommended. Individualised patient profiles provide important information for VD mitigating measures tailored to the person. Further, future projects should essentially deal with the complexity of vulvar-vaginal dryness as part of the Sicca syndrome in individuals with FS phenotype, in order to prevent genital female cancers which may occur at any age. In contrast to the human papilloma virus as possible trigger of the disease, the role of the vulvar-vaginal dryness as an important risk factor is strongly underestimated in currently applied diagnostic and treatment approaches.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19029156
- 003
- CZ-PrNML
- 005
- 20210219152022.0
- 007
- ta
- 008
- 190813s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s13167-019-00164-3 $2 doi
- 035 __
- $a (PubMed)30984316
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Goncharenko, Vadym $u Gynaecologic Department, Clinical Hospital "Pheophania", Kyiv, Ukraine.
- 245 10
- $a Vaginal dryness: individualised patient profiles, risks and mitigating measures / $c V. Goncharenko, R. Bubnov, J. Polivka, P. Zubor, K. Biringer, T. Bielik, W. Kuhn, O. Golubnitschaja,
- 520 9_
- $a Vaginal dryness (VD) affects both pre- and postmenopausal women at any age. Since the hormonal regulation changes during the climacteric period are considered as being the main course of the VD, affected women prefer not to talk about the problem. However, the problem does exist, and unfortunately if any, relatively minor group in the population possesses the health literacy at sufficient level to understand that VD is a suboptimal health condition which carries a multi-factorial character. Thereby, some of the contributing factors are clearly preventable and, therefore, if treated properly, have a potential to milden the VD. Current chapter demonstrates specific signs and symptoms of Flammer syndrome in women suffering from vaginal dryness, although individualised patient profiles clearly discriminate between pre- and postmenopausal women regarding the subgroup-specific symptoms. Noteworthy, about 20% of the VD patients involved in the study notify a delayed or even impaired wound healing observed for themselves over a couple of years. Optimising modifiable risk factors accompanying FS phenotype at the level of primary prevention is strongly recommended. Individualised patient profiles provide important information for VD mitigating measures tailored to the person. Further, future projects should essentially deal with the complexity of vulvar-vaginal dryness as part of the Sicca syndrome in individuals with FS phenotype, in order to prevent genital female cancers which may occur at any age. In contrast to the human papilloma virus as possible trigger of the disease, the role of the vulvar-vaginal dryness as an important risk factor is strongly underestimated in currently applied diagnostic and treatment approaches.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bubnov, Rostyslav $u Ultrasound Department, Clinical Hospital "Pheophania", Kyiv, Ukraine. 3Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, Kyiv, Ukraine.
- 700 1_
- $a Polivka, Jiri $u 4Department of Histology and Embryology and Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic. 5Department of Neurology, University Hospital Pilsen, Pilsen, Czech Republic.
- 700 1_
- $a Žúbor, Pavol, $d 1975- $u 6Department of Obstetrics and Gynaecology, Jessenius Faculty of Medicine, Martin University Hospital, Martin, Slovak Republic. 7Division of Oncology, Biomedical Centre Martin, Jessenius Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovak Republic. $7 xx0117542
- 700 1_
- $a Biringer, Kamil $u 6Department of Obstetrics and Gynaecology, Jessenius Faculty of Medicine, Martin University Hospital, Martin, Slovak Republic.
- 700 1_
- $a Bielik, Tibor $u 6Department of Obstetrics and Gynaecology, Jessenius Faculty of Medicine, Martin University Hospital, Martin, Slovak Republic.
- 700 1_
- $a Kuhn, Walther $u Centre of Obstetrics, Gynaecology and Gynaecologic Oncology, DonauIsar Klinikum Deggendorf-Dingolfing, Landau, Germany.
- 700 1_
- $a Golubnitschaja, Olga $u 9Radiological clinic, UKB, Rheinische Friedrich-Wilhelms-University of Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany. 10Breast Cancer Research Centre, UKB, Rheinische Friedrich-Wilhelms-University of Bonn, Bonn, Germany. 11Centre for Integrated Oncology, UKB, Cologne-Bonn, Rheinische Friedrich-Wilhelms-University of Bonn, Bonn, Germany.
- 773 0_
- $w MED00181668 $t The EPMA journal $x 1878-5077 $g Roč. 10, č. 1 (2019), s. 73-79
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30984316 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20210219152020 $b ABA008
- 999 __
- $a ind $b bmc $g 1434305 $s 1067616
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 10 $c 1 $d 73-79 $e 20190302 $i 1878-5077 $m The EPMA journal $n EPMA J $x MED00181668
- LZP __
- $a Pubmed-20190813